UBS Downgrades InterMune To Neutral By: Benzinga via Benzinga August 28, 2014 at 10:43 AM EDT Analysts at UBS downgraded InterMune (NASDAQ: ITMN) from Buy to Neutral. The price target for InterMune has been raised from $52.00 ... Read More >>